Chargement en cours...
New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors
The development of effective and well-tolerated biologic therapies has advanced the management of psoriasis by enabling clinicians to treat underlying disease mechanisms. Biologics approved for the treatment of moderate-to-severe psoriasis include three tumor necrosis factor alpha inhibitors and an...
Enregistré dans:
| Publié dans: | Dermatol Ther |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Blackwell Publishing Ltd
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4657465/ https://ncbi.nlm.nih.gov/pubmed/26201310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.12251 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|